...
首页> 外文期刊>Journal of the European Academy of Dermatology and Venereology: JEADV >Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study
【24h】

Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study

机译:ATX-101(脱氧胆酸)的功效,患者报告的结局和安全性,这是一种用于减少不必要的脑膜下脂肪的可注射药物:一项来自III期,随机,安慰剂对照研究的结果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Unwanted submental fat (SMF) may result in an unattractive chin profile and dissatisfaction with appearance. An approved and rigorously tested non-surgical method for SMF reduction is lacking.
机译:背景有害的脑下脂肪(SMF)可能会导致下巴轮廓不吸引人,并且外观不满意。缺少用于减少SMF的经过批准且经过严格测试的非手术方法。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号